Chongqing, China · Companies

Kanghua Ruiming

Kanghua Ruiming ranks among China’s largest specialized ophthalmic diagnostic equipment manufacturers, serving over 10,000 medical institutions across 136 countries. The company operates from a 35,000 m² production facility in Chongqing’s Beibei District, manufacturing a broad range of eye examination instruments including automated fundus cameras, slit lamp microscopes, and visual field analyzers.

Company Overview

Originally established as Chongqing Kanghua Technology Co., Ltd. in 1996, the company restructured and rebranded as Kanghua Ruiming in 2009, subsequently converting to a joint-stock company in 2012. The firm has built its reputation on developing China’s first generation of digital ophthalmic diagnostic equipment, including the country’s earliest digital fundus fluorescein angiography system and the world’s first digital slit lamp microscope.

The company maintains in-house capabilities spanning optical design, precision mechanics, electronics, ultrasonic technology, and software development. Manufacturing operations follow ISO 9001:2015 and ISO 13485:2016 quality management standards, with CE marking certification for European market access. Selected products, including fundus cameras and projection perimeters, have obtained FDA 510(k) clearance for the US market.

Core Products

APS-70X Automatic Non-Mydriatic Fundus Camera

The flagship APS-70X represents Kanghua Ruiming’s advancement toward intelligent diagnostic automation. This system performs fully automated retinal imaging without requiring pupil dilation, featuring:

  • Intelligent panoramic auto-focus with automatic eye tracking
  • Automated fundus switching, exposure adjustment, and image capture
  • Automatic mosaic stitching for wide-field retinal documentation
  • Touch-screen operation eliminating joystick manipulation
  • Automated pupil measurement

The device targets diabetic retinopathy screening programs, routine ophthalmology examinations, and endocrinology departments conducting fundus assessments for diabetic patients.

Slit Lamp Microscopes (SLM Series)

The SLM-1ER, SLM-2ER, and SLM-3ER series have received FDA 510(k) clearance (K171877). These digital slit lamps integrate imaging, digitization, and network connectivity for anterior segment examination documentation.

Projection Perimeters (APS-T Series)

Visual field analyzers including the APS-T90 and APS-T00 models have obtained both CE and FDA certifications. Kanghua claims to have developed China’s first computerized projection perimeter.

Additional Diagnostic Equipment

  • APS-BER/CER fundus fluorescein angiography systems
  • APS-2000AER visual electrophysiology systems (VEP, ERG, EOG)
  • CAS-2000BER ophthalmic A/B ultrasound scanners
  • Dry eye analyzers

Technology & Innovation

Kanghua Ruiming holds multiple “first in China” claims in ophthalmic diagnostics:

  • First Chinese manufacturer to implement non-mydriatic fundus photography
  • First to develop workstation-based ophthalmic ultrasound systems
  • First digital fundus fluorescein angiography system, ending the film-based era
  • Developer of what was described as the world’s first digital slit lamp
  • First Chinese manufacturer to realize VEP, ERG, and EOG electrophysiology integration

The company has undertaken national-level scientific research projects and fully implements CAD/CAM/CAPP/PDM digital design with NC digital manufacturing and ERP systems.

Market Presence

With a domestic user base exceeding 6,000 institutions among its 10,000+ global customers, Kanghua Ruiming has established distribution channels across 136 countries and regions. The company maintains over 100 market service personnel distributed throughout Chinese provinces for after-sales support.

Primary customer segments include:

  • Hospital ophthalmology departments
  • Endocrinology departments (diabetic fundus screening)
  • Optometry centers
  • Research institutions
  • Health screening centers

Key Milestones

  • 1996: Established Chongqing Kanghua Technology Co., Ltd.
  • 2000s: Developed China’s first digital fundus fluorescein angiography and digital slit lamp
  • 2009: Rebranded as Kanghua Ruiming; obtained EU CE certification
  • 2012: Restructured as joint-stock company
  • 2017: FDA 510(k) clearance for SLM series slit lamps (K171877)
  • 2020s: Launched APS-70X fully automatic fundus imaging system

Frequently Asked Questions

What certifications do Kanghua Ruiming products hold?

The company maintains ISO 9001:2015 and ISO 13485:2016 quality management system certifications. Products carry CE marking for European markets, and selected devices including fundus cameras, projection perimeters, and slit lamps have obtained FDA 510(k) clearance.

Is Kanghua Ruiming a publicly traded company?

Kanghua Ruiming operates as a joint-stock company (restructured in 2012) but is not listed on public stock exchanges.

What makes the APS-70X different from traditional fundus cameras?

The APS-70X eliminates manual joystick operation through fully automated image capture, including automatic focusing, eye tracking, exposure adjustment, and mosaic stitching. Touch-screen controls allow non-specialist operators to capture diagnostic-quality retinal images.

Last modified: January 16, 2026

Sources

Publicly available references used for the data on this page. See data methodology for verification standards.